
Phase 147 (The CJ Planets) - The Uncanny Incredible Wiki
Phase 147 is the 147th phase created by CJ, shown in his 150 Phases, 163 Phases, and 200 phases template. Appearance. Original: Phase 147 looks like a creepy smiling mask with …
Phase 147.01 (Raysofdoom2665) - The Uncanny Incredible Wiki
Phase 147.01 is the 1st subphase of Phase 147 in raysofdoom2665's 500 phase template. It looks like a human with a crow mask and an hoodie. The origin for this is SCP-049 Phase 126 …
放射性药物开发商Abdera Therapeutics宣布ABD-147的IND申请 …
2024年5月23日 · The Phase 1, first-in-human, open-label clinical study aims to evaluate the safety and preliminary efficacy of 225Ac-ABD-147 in patients with SCLC or LCNEC who …
Phase 150 | The Canny Incredible Wiki | Fandom
Phase 150 is the 150th phase of Mr. Incredible Becoming Canny and the final phase of Mr. Incredible Becoming Canny (150 Phases). It has a sub-phase. Phase 150 appears to be a …
MIBU 2000 Phases (NightmareKing) | The Uncanny Templates Wiki …
Mr. Incredible Becoming Uncanny/Canny (Phase Collection) MIBU 2000 Phases (NightmareKing) KunaProduction's Template; Nightmare King Grimm's Phases 1901-2000; ... Phase 147. …
Phase 47 (The CJ Planets) - The Uncanny Incredible Wiki
Phase 47 is the forty-seventh phase in the history of Mr. Incredible Becoming Uncanny. Phase 47 looks like a blue spirit with its mouth open and glowing pupils. The origin is Anamoly …
Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 ...
2024年9月5日 · ABD-147 is a next-generation precision radiopharmaceutical biologic therapy designed to deliver Actinium-225 (225 Ac) to solid tumors expressing DLL3, a protein found on …
Idiot phase 147.5 - YouTube
2022年8月5日 · credit to @Juxyphlux for the beanos earrape
放射性药物开发商Abdera Therapeutics宣布ABD-147获FDA孤儿药 …
2024年9月6日 · ABD-147 is a next-generation precision radiopharmaceutical biologic therapy designed to deliver Actinium-225 (225Ac) to solid tumors expressing DLL3, a protein found on …
A Phase 1a/b, Open-label, Dose-escalation Study of the Safety ...
A Phase 1a/b, Open-label, Dose-escalation Study of the Safety, Pharmacokinetics, and Initial Efficacy of 225Ac-ABD147 in Patients with Small Cell Lung Cancer and Large Cell …
- 某些结果已被删除